artemisinin

Artemisinin (Qinghaosu) is a natural product, a sesquiterpene lactone, derived from Artemisia annua. Artemisinin has anti-malarial activity, as well as neuroprotective and anti-tumor activity.

Artemisinin B is a drug which may improve spatial memory in dementia patients and alter the levels of inflammatory cytokines in the hippocampus and the cortex. Artemisinin B may inhibit neuroinflammation and exert neuroprotective effects on cognitive functions by modulating the TLR4-MyD88-NF-κB signaling pathway. Artemisinin B has shown potential in the treatment of neuroinflammatory diseases.

Piperaquine is a bis-quinoline antimalarial compound, a companion compound to artemisinin.Piperaquine is a component of Eurartesim, which is commonly used in the study of malaria infections.

Piperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent.

Artemisinin (Arteannuin, Qinghaosu, Qing Hau Sau) is a useful organic compound for research related to life sciences and the catalog number is T131541.

Artemisinin-D3 is the deuterated form of Artemisinin. Artemisinin (T0392) (Qinghaosu) is a sesquiterpene lactone with antimalarial properties, isolated from the aerial parts of the plant Artemisia annua L. Artemisinin (T0392) inhibits the AKT signaling pathway by reducing pAKT levels in a dose-dependent manner. This compound also decreases cancer cell proliferation, migration, invasion, tumor growth, and metastasis, while offering neuroprotective effects.

Artemisinin (Standard) is a reference standard for research and analysis in studies involving Artemisinin. Artemisinin (Qinghaosu) is a natural product, a sesquiterpene lactone, derived from Artemisia annua. Artemisinin has anti-malarial activity, as well as neuroprotective and anti-tumor activity.

Artemisinin-[13C,D4] (Standard) is a reference standard of Artemisinin-[13C,D4] intended for quantitative analysis, quality control, and related biochemical research applications.

Dihydroartemisinin (Artenimol) is an antimalarial drug.

α-Dihydroartemisinin (α-Dihydroqinghaosu) is an intermediate of artemisinin-based antimalarial compounds with good antimalarial and anticancer activity, and can be used in the study of lupus erythematosus.

Anhydro Dihydro Artemisinin is a natural product from Artemisia carvifolia Buch.-Ham. ex Roxb.

Dihydroartemisinin (mixture of α and β isomers) is a useful organic compound for research related to life sciences. The catalog number is T64399 and the CAS number is 131175-87-6.

Deoxyartemisinin (2-deoxyartemisinin), a compound derived from Artemisia annua, has anti-inflammatory and anti-ulcer effects and is used in the study of malaria.

Dihydroartemisinin diketo aldehyde is an impurity of Artemether.

Artemether (CGP 56696) is an antimalarial agent used to treat acute uncomplicated malaria.

Artelinic acid is a water-soluble artemisinin analog with antimalarial activity and is used for the treatment of multi-drug resistant strains of Plasmodium falciparum.

β-Aminoarteether (SM934 free base), an orally active derivative of Artemisinin, serves a pivotal role in the research of inflammation and autoimmune disorders, including those related to lupus diseases.

Artesunate (WR-256283) is part of the artemisinin group of drugs that treat malaria. It is a semi-synthetic derivative of artemisinin, Artesunate is soluble in water but has poor stability in aqueous solutions at neutral or acid pH.

3-AMINO-1,2,4-TRIAZINE is an aromatic bioactive compound. It has been used to synthesize a variety of drugs, including the antifungal drug fluconazole, the anti-inflammatory drug ibuprofen and the anticancer drug paclitaxel. It has also been used in the design of new drugs, such as the anti-AIDS drug zidovudine and the anti-malarial drug artemisinin.

Naphthoquine phosphate is a broad-spectrum 4-aminoquinoline antimalarial compound with oral activity that may affect viral entry and post-entry replication.Naphthoquine phosphate has hepatic vascular center toxicity and is often used with artemisinin to treat malaria.

Amorphadiene serves as a precursor to the antimalarial drug artemisinin, generated via the cyclization of farnesyl pyrophosphate (FPP) in yeast, catalyzed by amorphadiene synthase (ADS).

ART631 is a dimeric artemisinin compound with strong anti-leukemia activity and favorable pharmacological properties, characterized by a structure connected via a two-carbon chain.

ACT-451840 is capable of eliminating both sensitive and resistant strains of Plasmodium falciparum and has the advantages of oral activity, potency, low toxicity, rapid onset of action in all asexual blood stages of Plasmodium, and a mechanism of action similar to that of artemisinin derivatives. In in vivo experiments, ACT-451840 showed excellent antimalarial effects at a dose of 30 mg/kg, with a parasite reduction rate of 99.80%.